| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5622206 | Thrombosis Research | 2016 | 7 Pages |
Abstract
The outcome of ITI therapy seems to be stable over time, and treatment regimens remain heterogeneous. The use of low dose regimens however is considered more frequently.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
K. Holstein, A. Batorova, M. Carvalho, K. Fijnvandraat, P. Holme, K. Kavakli, T. Lambert, A. Rocino, V. Jiménez-Yuste, J. Astermark, European Haemophilia Therapy Strategy Board (EHTSB) European Haemophilia Therapy Strategy Board (EHTSB),